SLC7A5 and neoplasm: L-type amino acid transporter 1 (LAT1) inhibitors such as BCH or KYT0353 strongly reduced the dominance of RasG12V;scrib−/− tumour cells over wild-type cells by curtailing mTOR signalling [47].